1. 3‐aminopyrazolopyrazine derivatives as spleen tyrosine kinase inhibitors. (27th August 2016) Authors: Shen, Jiayi; Li, Xiaokai; Zhang, Zhang; Luo, Jingfeng; Long, Huoyou; Tu, Zhengchao; Zhou, Xiaoping; Ding, Ke; Lu, Xiaoyun Journal: Chemical biology & drug design Issue: Volume 88:Number 5(2016) Page Start: 690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adeno-associated virus-mediated cancer gene therapy: Current status. Issue 2 (28th January 2015) Authors: Luo, Jingfeng; Luo, Yuxuan; Sun, Jihong; Zhou, Yurong; Zhang, Yajing; Yang, Xiaoming Journal: Cancer letters Issue: Volume 356:Issue 2(2015)Part B Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adeno-associated virus-mediated cancer gene therapy: Current status. Issue 2 (28th January 2015) Authors: Luo, Jingfeng; Luo, Yuxuan; Sun, Jihong; Zhou, Yurong; Zhang, Yajing; Yang, Xiaoming Journal: Cancer letters Issue: Volume 356:Issue 2(2015)Part B Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hybrid pyrimidine alkynyls inhibit the clinically resistance related Bcr-AblT315I mutant. Issue 17 (1st September 2015) Authors: Lu, Xiaoyun; Zhang, Zhang; Ren, Xiaomei; Pan, Xiaofeng; Wang, Deping; Zhuang, Xiaoxi; Luo, Jingfeng; Yu, Rongmin; Ding, Ke Journal: Bioorganic & medicinal chemistry letters Issue: Volume 25:Issue 17(2015) Page Start: 3458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗